Chris H. Takimoto - 30 Jul 2021 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Medical Officer
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
30 Jul 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 17:42:30 UTC
Next filing
19 Nov 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IGMS Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 30 Jul 2021 Common Stock 150,000 $68.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option shall vest on July 30, 2022, and 1/48 of the shares subject to the option shall vest each month thereafter on the same day of the month, subject to the Reporting Person remaining a service provider through each such date.